Trial site
Santiago
- 18running trials
- 18closed trials
The trials here
What the 36 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)6 trials
- Multiple sclerosis5 trials
- Hidradenitis suppurativa4 trials
- Asthma3 trials
- COPD3 trials
- Ulcerative colitis2 trials
- Alopecia areata1 trial
- Bronchiectasis1 trial
- Childhood cancers1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Chronic spontaneous urticaria1 trial
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- and 9 more
- Phase
- Phase 318 trials
- Phase 216 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed12 trials
- Active, not recruiting11 trials
- Recruiting6 trials
- Terminated6 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Sanofi36 trials
Running trials
Recruiting
Recruiting
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma1 recruiting
- COPD1 recruiting
- Crohn's disease1 recruiting
- Hidradenitis suppurativa1 recruiting
- Nephrotic syndrome1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Terminated
Completed
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Terminated
Completed
A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis
Completed
Terminated
Completed
A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa
Completed
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Terminated
Completed
Terminated
Terminated
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026